| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.09 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.29 | 0.09 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |